{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:44:13Z","timestamp":1790959453011,"version":"4.1.0"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,6,25]]},"DOI":"10.18632\/aging.103257","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T18:02:56Z","timestamp":1593108176000},"page":"11517-11529","source":"Crossref","is-referenced-by-count":26,"title":["hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p\/TEP1 axis"],"prefix":"10.18632","volume":"12","author":[{"given":"Shan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Lab of Liver Disease, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, People\u2019s Hospital of Yunxi, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Lab of Liver Disease, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Liver Diseases, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Lab of Liver Disease, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Lab of Liver Disease, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis.","volume":"3","author":"Friedman","year":"2013","journal-title":"Compr Physiol"},{"key":"2","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets.","volume":"2","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis.","volume":"12","author":"Hoshida","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation.","volume":"1","author":"Friedman","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.","volume":"6","author":"Cui","year":"2018","journal-title":"Gut"},{"key":"6","doi-asserted-by":"publisher","first-page":"e0176173","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation.","volume":"1","author":"Ben-Ari","year":"2017","journal-title":"PLoS One"},{"key":"7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/hep.29523","article-title":"NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice.","volume":"6","author":"Feldstein","year":"2018","journal-title":"Hepatology"},{"key":"8","doi-asserted-by":"publisher","first-page":"154497","DOI":"10.1016\/j.cyto.2018.07.028","article-title":"Type 3 cytokines in liver fibrosis and liver cancer.","volume":"12","author":"Shoukry","year":"2019","journal-title":"Cytokine"},{"key":"9","doi-asserted-by":"publisher","first-page":"eaar7754","DOI":"10.1126\/sciimmunol.aar7754","article-title":"Type 3 cytokines IL-17A and IL-22 drive TGF-\u03b2-dependent liver fibrosis.","volume":"3","author":"Shoukry","year":"2018","journal-title":"Sci Immunol"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13360","article-title":"Chemically modified hepatic stellate cell selective carrier mannose-6-phosphate carrying salvianolic acid B alleviates liver fibrosis in vivo.","author":"Li","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fphar.2019.00322","article-title":"Salvianolic acid B inhibits activation of human primary hepatic stellate cells through downregulation of the myocyte enhancer factor 2 signaling pathway.","volume":"1","author":"Xu","year":"2019","journal-title":"Front Pharmacol"},{"key":"12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.metabol.2015.08.004","article-title":"Non-coding RNA-mediated epigenetic regulation of liver fibrosis.","volume":"6","author":"Li","year":"2015","journal-title":"Metabolism"},{"key":"13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13578-018-0259-6","article-title":"The roles of lncRNA in hepatic fibrosis.","volume":"8","author":"Wu","year":"2018","journal-title":"Cell Biosci"},{"key":"14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/1566523219666191107113046","article-title":"Non-coding RNA associated competitive endogenous RNA regulatory network: novel therapeutic approach in liver fibrosis.","volume":"1","author":"Li","year":"2019","journal-title":"Curr Gene Ther"},{"key":"15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tig.2016.03.002","article-title":"Circular RNA expression: its potential regulation and function.","volume":"3","author":"Salzman","year":"2016","journal-title":"Trends Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges.","volume":"49","author":"Kjems","year":"2013","journal-title":"Nature"},{"key":"17","doi-asserted-by":"publisher","first-page":"58405","DOI":"10.18632\/oncotarget.16881","article-title":"Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma.","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/cam4.1574","article-title":"Circular RNAs in hepatocellular carcinoma: functions and implications.","volume":"7","author":"Guo","year":"2018","journal-title":"Cancer Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1002\/jcp.26154","article-title":"Progress and prospects of circular RNAs in hepatocellular carcinoma: novel insights into their function.","volume":"23","author":"Xu","year":"2018","journal-title":"J Cell Physiol"},{"key":"20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5582\/bst.2018.01311","article-title":"Preoperative evaluation of the degree of liver fibrosis based on matter-element analysis using serological indicators in patients with hepatocellular carcinoma.","volume":"1","author":"Zheng","year":"2019","journal-title":"Biosci Trends"},{"key":"21","doi-asserted-by":"publisher","first-page":"160726","DOI":"10.1155\/2012\/160726","article-title":"Salvianolic acid B attenuates rat hepatic fibrosis via downregulating angiotensin II signaling.","volume":"201","author":"Liu","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3748\/wjg.v8.i4.679","article-title":"Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.","volume":"8","author":"Zhang","year":"2002","journal-title":"World J Gastroenterol"},{"key":"23","first-page":"71","article-title":"[Effects of salvianolic acid B on lipid peroxidation and metalloproteinase-2 activity in fibrotic liver in rat].","volume":"3","author":"Liu","year":"2010","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5009\/gnl18081","article-title":"Relationship between telomere maintenance and liver disease.","volume":"1","author":"Saab","year":"2019","journal-title":"Gut Liver"},{"key":"25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.275.5302.973","article-title":"A mammalian telomerase-associated protein.","volume":"27","author":"Robinson","year":"1997","journal-title":"Science"},{"key":"26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers.","volume":"1","author":"Schwabe","year":"2015","journal-title":"Nat Protoc"},{"key":"27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/abbs\/gmt143","article-title":"Isolation and culture of hepatic stellate cells from mouse liver.","volume":"4","author":"Qin","year":"2014","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"28","doi-asserted-by":"publisher","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice.","volume":"11","author":"Murray","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-7113-8_11","article-title":"Isolation and culture of primary murine hepatic stellate cells.","volume":"162","author":"Weiskirchen","year":"2017","journal-title":"Methods Mol Biol"},{"key":"30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41419-018-0623-9","article-title":"Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K\/AKT\/HIF-1\u03b1 signaling pathway.","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis"},{"key":"31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.","volume":"13","author":"Pera","year":"2009","journal-title":"Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000484904","article-title":"Xia-yu-xue decoction inhibits intestinal epithelial cell apoptosis in CCl4-induced liver fibrosis.","volume":"4","author":"Liu","year":"2017","journal-title":"Cell Physiol Biochem"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:28:39Z","timestamp":1599078519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,30]]}},"alternative-id":["103257","32584784"],"URL":"https:\/\/doi.org\/10.18632\/aging.103257","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}